Thymosin beta-4 functions as a major actin-sequestering protein, binding to monomeric G-actin and preventing its polymerization into filamentous F-actin
This applies to PPO, HMO, Medicare, and Medicaid
If patients have typical symptoms of GERD (heartburn or acid regurgitation or both) and no alarm symptoms, an 8-week trial of acid suppression therapy is appropriate If symptoms resolve completely with acid suppression but return when treatment is discontinued, the patient may have GERD but probably requires esophagogastroduodenoscopy for further evaluation of recurrent symptoms when PPI therapy has been held for 2 to 4 weeks If the patient has little or no response to acid suppression, further investigation is needed Atypical Symptoms of GERD GERD may cause or contribute to many different clinical syndromes
Maintenance phase: After loading, protocols typically reduce to 2-2.5mg once weekly or 2mg twice monthly
BPC-157 Cycle Length: How Long, How Often, and When to Stop The standard BPC-157 cycle is four to eight weeks of daily dosing followed by a two to four week rest period
